MTND1P35

Across TCGA pan-cancer cohorts, MTND1P35 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MTND1P35 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MTND1P35 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND1P35 expression acts as an unfavorable survival marker.

OV, SKCM, and BLCA are the cancer types where MTND1P35 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.028	0.759	.002	144	view →
SKCM	DFS	Tertile	All	0.036	0.738	<.001	108	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
CESC	DFS	Tertile	III,IV	0.190	0.727	.006	36	view →
ESCA	OS	Tertile	All	0.176	0.700	.010	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MTND1P35–OV (OS)

Open the OV breakdown →